|
⚲
|
| Message |
|---|
| Happy Holidays!! thanks for using AUM13F!! |
| Paradigm Biocapital Advisors LP
✚
|
|
|---|---|
| CRD # | 312544 |
| SEC # | 801-120338 |
| CIK # | 0001855655 |
| AUM | $3.1 B (2025-03-28) |
| Employees | 9 (56% Investors, 0% Brokers) |
| Phone | 646-970-2568 |
| Address | 767 Third Avenue New York, NY 10017 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Nuvalent Inc | 0.4 | ||
| Arcellx Inc | 0.3 | ||
| Merus NV | 0.2 | ||
| Revolution Medicines Inc | 0.2 | ||
| Tarsus Pharmaceuticals Inc | 0.1 | ||
| Vaxcyte Inc | 0.1 | ||
| BeiGene Ltd | 0.1 | ||
| Edgewise Therapeutics Inc | 0.1 | ||
| UNUM Therapeutics Inc | 0.1 | ||
| Janux Therapeutics Inc | 0.1 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| HF | Paradigm Biocapital International Fund Ltd | [2021-06-23] | 591.6 | 2,643.7 |
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 2.6 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 1 | 0.4 |
| Total | 4 | 3.1 |
| By Discretionary | ||
| Discretionary | 4 | 3.1 |
| Non-Discretionary | 0 | 0.0 |
| Total | 4 | 3.1 |
| By Non-United States Persons | ||
| Non-United States Persons | 2.6 | |
| United States Persons | 0.4 | |
| Total | 4 | 3.1 |
| Form D Directors | # Filings | # Firms | 2011 - 2025 |
|---|---|---|---|
| Alaina Danley | 108 | ||
| Victor Murray | 56 | ||
| Frank Meyer | 3 | ||
| Senai Asefaw | 3 | ||
| Paradigm Biocapital Advisors LP | 2 |
| EDGAR Form | CIK | 2011 - 2025 |
|---|---|---|
| 13F-HR | [0001855655] | |
| 3 | [0001855655] | |
| 4 | [0001855655] | |
| SC 13G | [0001855655] |
| Form 3/4/5 Subject | 2011 - 2025 |
|---|---|
| Paradigm BioCapital International Fund Ltd. | |
| Asefaw Senai | |
| Olema Pharmaceuticals, Inc. | |
| Paradigm BioCapital Advisors GP LLC | |
| Paradigm Biocapital Advisors LP |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Cinctive Capital Management LP
✚
|
NY | 3.1 |
|
Scopus Asset Management LP
✚
|
NY | 3.1 |
|
Caption Management LLC
✚
|
OK | 3.1 |
|
FNY Investment Advisers LLC
✚
|
NY | 3.1 |
|
Gladius Capital Management LP
✚
|
UT | 3.1 |
|
Stevens Capital Management LP
✚
|
PA | 3.0 |
|
CoreCommodity Management LLC
✚
|
CT | 3.0 |
|
Variant Investments LLC
✚
|
OR | 3.0 |
|
Rimrock Capital Management LLC
✚
|
CA | 3.0 |
|
Carronade Capital Management LP
✚
|
CT | 3.0 |